Search

Your search keyword '"Maria, Bjerke"' showing total 136 results

Search Constraints

Start Over You searched for: Author "Maria, Bjerke" Remove constraint Author: "Maria, Bjerke"
136 results on '"Maria, Bjerke"'

Search Results

1. Brain age as a biomarker for pathological versus healthy ageing – a REMEMBER study

2. Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method

3. CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response

4. A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial

6. Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid Precursor Protein - β in the Subcortical Small Vessel Type of Dementia

7. Baseline levels of soluble amyloid precursor proteins predict conversion to subcortical small-vessel disease

8. Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review

9. Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations

10. Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease

11. Inter- and Intra-Scanner Variability of Automated Brain Volumetry on Three Magnetic Resonance Imaging Systems in Alzheimer’s Disease and Controls

12. SARS-CoV-2 RNA and antibodies in tear fluid

13. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.

14. A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms

15. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration

16. Prognostic value of left ventricular global constructive work in patients with cardiac amyloidosis

17. Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke

18. No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis

19. Subjective Cognitive Impairment Is a Predominantly Benign Condition in Memory Clinic Patients Followed for 6 Years: The Gothenburg-Oslo MCI Study

20. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum

21. New insights into the genetic etiology of Alzheimer's disease and related dementias

22. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging

23. Associating Alzheimer’s disease pathology with its cerebrospinal fluid biomarkers

24. Microtubule associated protein tau p.R406W patient carriers present with a nonconforming clinical phenotype

26. Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer’s Disease in a Clinical Setting: A REMEMBER Study

27. Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease

28. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis

29. Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy

30. Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

32. 7α-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid reflects the integrity of the blood-brain barrier

33. Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia

34. First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays

35. Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study

36. Investigating Tissue-Specific Abnormalities in Alzheimer's Disease with Multi-Shell Diffusion MRI

37. Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease

38. Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia

39. Development and analytical characterization of novel tau Simoa assays targeting full‐length tau in CSF and mid‐tau in CSF and plasma

41. Inter‐ and intra‐scanner variability of icobrain DM automated brain volumetry software on three different MRI systems

42. Blood-brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein-β in patients with subcortical small-vessel disease

43. Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects

44. Hippocampal Sclerosis in Frontotemporal Dementia

45. SARS-CoV-2 RNA and antibodies in tear fluid

46. Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays

47. International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease

48. CSF and Blood Neurofilament Levels in Athletes Participating in Physical Contact Sports: A Systematic Review

49. Amyloid-β

50. A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms

Catalog

Books, media, physical & digital resources